The company will use the funds to grow the company, increase manufacturing operations and put in place more products in the research and development pipeline.

Molly Gibson, president of future science at Lila Sciences, explains how the company’s superintelligence will reshape research across life, chemical and material sciences.

The partnership combines Atropos Health’s expertise in real-world evidence generation with Databricks’ data intelligence capabilities.

The partners will develop and clinically validate an AI tool that integrates into EHRs to accelerate the diagnosis of hypophosphatasia, a rare genetic bone disorder.

Manulife Group Benefits plan members will have virtual access to Maven’s digital platform, connecting them to a global network of providers.

The company is offering 7.9 million of its common stock at an initial price of $19 per share, with shares trading under the ticker symbol OMDA.

Elsa provides a secure platform for scientific reviewers and investigators to access internal documents.

The aim is to use See-Mode’s thyroid ultrasound as a way to enhance workflow and diagnostic accuracy at RadNet imaging centers.

The company will grow its clinical team and expand its offerings across GI partner clinics representing 700 physicians, after an 800% rise in patient volume.

Alexandre Momeni, a partner at General Catalyst, describes how the VC firm funds visionary founders building frontier technologies while balancing high-risk bets with responsible innovation and…